Phillips Medisize

Drug Delivery Leader: Expanding Therapeutic Targets For Injection And Inhalation

Geraldine Venthoye, Chief Scientific Officer at Phillips Medisize, joins Supplier Horizons host Tom von Gunden to discuss recent advancements in inhalation and injection technologies aimed at addressing a wider range of patient needs. They explore the formulation and delivery system challenges associated with complex large-molecule biologics, such as vaccines, immunotherapies, and cell and gene therapies. Venthoye also shares insights on improving patient access and affordability, the role of digital health and connected devices, strategies for managing chronic diseases, and commitments to social and environmental responsibility.